The list of substances that are unlikely to benefit from the reduced information requirements, the so-called ‘Annex III inventory’, has been withdrawn.

Companies can continue registering substances with reduced information requirements if the substances do not fulfil the criteria described in Annex III of REACH. When assessing if the substance meets the criteria described in Annex III, checking the inventory is no longer needed.